These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27937063)

  • 1. Recent advances in proteomic applications for schistosomiasis research: potential clinical impact.
    Sotillo J; Doolan D; Loukas A
    Expert Rev Proteomics; 2017 Feb; 14(2):171-183. PubMed ID: 27937063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of recent findings in schistosome proteomics.
    Driguez P; McManus DP; Gobert GN
    Expert Rev Proteomics; 2016; 13(1):19-33. PubMed ID: 26558506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosomes--proteomics studies for potential novel vaccines and drug targets.
    DeMarco R; Verjovski-Almeida S
    Drug Discov Today; 2009 May; 14(9-10):472-8. PubMed ID: 19429506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-depth proteomic characterization of Schistosoma haematobium: Towards the development of new tools for elimination.
    Sotillo J; Pearson MS; Becker L; Mekonnen GG; Amoah AS; van Dam G; Corstjens PLAM; Murray J; Mduluza T; Mutapi F; Loukas A
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007362. PubMed ID: 31091291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic and immunomic analysis of Schistosoma mekongi egg proteins.
    Thiangtrongjit T; Adisakwattana P; Limpanont Y; Dekumyoy P; Nuamtanong S; Chusongsang P; Chusongsang Y; Reamtong O
    Exp Parasitol; 2018 Aug; 191():88-96. PubMed ID: 30009810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schistosomiasis vaccine development--the current picture.
    Waine GJ; McManus DP
    Bioessays; 1997 May; 19(5):435-43. PubMed ID: 9174407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological Considerations for
    Driciru E; Koopman JPR; Cose S; Siddiqui AA; Yazdanbakhsh M; Elliott AM; Roestenberg M
    Front Immunol; 2021; 12():635985. PubMed ID: 33746974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative proteomic analysis of the tegumental proteins from Schistosoma mansoni schistosomula reveals novel potential therapeutic targets.
    Sotillo J; Pearson M; Becker L; Mulvenna J; Loukas A
    Int J Parasitol; 2015 Jul; 45(8):505-16. PubMed ID: 25910674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials.
    Capron A; Riveau G; Capron M; Trottein F
    Trends Parasitol; 2005 Mar; 21(3):143-9. PubMed ID: 15734662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosome proteomics: updates and clinical implications.
    Castro-Borges W; Wilson RA
    Expert Rev Proteomics; 2022; 19(4-6):247-261. PubMed ID: 36331139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schistosome membrane proteins as vaccines.
    Loukas A; Tran M; Pearson MS
    Int J Parasitol; 2007 Mar; 37(3-4):257-63. PubMed ID: 17222846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Still hope for schistosomiasis vaccine.
    Ricciardi A; Ndao M
    Hum Vaccin Immunother; 2015; 11(10):2504-8. PubMed ID: 26176659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing a vaccine to prevent human schistosomiasis.
    Merrifield M; Hotez PJ; Beaumier CM; Gillespie P; Strych U; Hayward T; Bottazzi ME
    Vaccine; 2016 Jun; 34(26):2988-2991. PubMed ID: 27036511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Anti-Schistosoma Approaches in The People's Republic of China: Development of Diagnostics, Vaccines and Other New Techniques Belonging to the 'Omics' Group.
    Chen SB; Ai L; Hu W; Xu J; Bergquist R; Qin ZQ; Chen JH
    Adv Parasitol; 2016; 92():385-408. PubMed ID: 27137453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinomics for the major blood feeding helminths of humans.
    Loukas A; Gaze S; Mulvenna JP; Gasser RB; Brindley PJ; Doolan DL; Bethony JM; Jones MK; Gobert GN; Driguez P; McManus DP; Hotez PJ
    OMICS; 2011 Sep; 15(9):567-77. PubMed ID: 21679087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of adult Schistosoma mekongi somatic and excretory-secretory proteins.
    Reamtong O; Simanon N; Thiangtrongjit T; Limpanont Y; Chusongsang P; Chusongsang Y; Anuntakarun S; Payungporn S; Phuphisut O; Adisakwattana P
    Acta Trop; 2020 Feb; 202():105247. PubMed ID: 31672487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refolding of the recombinant protein Sm29, a step toward the production of the vaccine candidate against schistosomiasis.
    Chura-Chambi RM; Nakajima E; de Carvalho RR; Miyasato PA; Oliveira SC; Morganti L; Martins EA
    J Biotechnol; 2013 Dec; 168(4):511-9. PubMed ID: 24084635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function analysis of apical membrane-associated molecules of the tegument of schistosome parasites of humans: prospects for identification of novel targets for parasite control.
    Leow CY; Willis C; Hofmann A; Jones MK
    Br J Pharmacol; 2015 Apr; 172(7):1653-63. PubMed ID: 25176442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of reverse vaccinology in Schistosoma vaccine development: advances and prospects].
    Feng XG; Sui CY; Yuan CX; Shao DH; Chen JX; Lin JJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):237-47. PubMed ID: 18038788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can schistosomiasis really be consigned to history without a vaccine?
    Bethony JM; Diemert DJ; Oliveira SC; Loukas A
    Vaccine; 2008 Jun; 26(27-28):3373-6. PubMed ID: 18513839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.